{"Title": "Bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology", "Year": 2020, "Source": "J. Med. Chem.", "Volume": "63", "Issue": 9, "Art.No": null, "PageStart": 4506, "PageEnd": 4516, "CitedBy": 4, "DOI": "10.1021/acs.jmedchem.9b01336", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084693935&origin=inward", "Abstract": "\u00a9 2020 American Chemical Society.RET receptor tyrosine kinase is a driver oncogene in human cancer. We recently identified the clinical drug candidate Pz-1, which targets RET and VEGFR2. A key in vivo metabolite of Pz-1 is its less active demethylated pyrazole analogue. Using bioisosteric substitution methods, here, we report the identification of NPA101.3, lacking the structural liability for demethylation. NPA101.3 showed a selective inhibitory profile and an inhibitory concentration 50 (IC50) of <0.003 \u03bcM for both RET and VEGFR2. NPA101.3 inhibited phosphorylation of all tested RET oncoproteins as well as VEGFR2 and proliferation of cells transformed by RET. Oral administration of NPA101.3 (10 mg/kg/day) completely prevented formation of tumors induced by RET/C634Y-transformed cells, while it weakened, but did not abrogate, formation of tumors induced by a control oncogene (HRAS/G12V). The balanced synchronous inhibition of both RET and VEGFR2, as well the resistance to demethylation, renders NPA101.3 a potential clinical candidate for RET-driven cancers.", "AuthorKeywords": null, "IndexKeywords": ["Animals", "Antineoplastic Agents", "Cell Line, Tumor", "Drug Discovery", "Female", "Humans", "Mice", "Mice, Inbred BALB C", "Models, Molecular", "Mutation", "Neoplasms", "NIH 3T3 Cells", "Polypharmacology", "Protein Binding", "Protein Kinase Inhibitors", "Proto-Oncogene Proteins c-ret", "Signal Transduction", "Vascular Endothelial Growth Factor Receptor-2"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85084693935", "SubjectAreas": [["Molecular Medicine", "BIOC", "1313"], ["Drug Discovery", "PHAR", "3002"]], "AuthorData": {"56380156300": {"Name": "Moccia M.", "AuthorID": "56380156300", "AffiliationID": "60017293", "AffiliationName": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 di Napoli \"Federico II\""}, "37016227400": {"Name": "Brescia A.", "AuthorID": "37016227400", "AffiliationID": "60017293", "AffiliationName": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 di Napoli \"Federico II\""}, "56704719000": {"Name": "Federico G.", "AuthorID": "56704719000", "AffiliationID": "60017293", "AffiliationName": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 di Napoli \"Federico II\""}, "57202725105": {"Name": "Santoro M.", "AuthorID": "57202725105", "AffiliationID": "60017293", "AffiliationName": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 di Napoli \"Federico II\""}, "55925394000": {"Name": "Carlomagno F.", "AuthorID": "55925394000", "AffiliationID": "60017293", "AffiliationName": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 di Napoli \"Federico II\""}, "55215012300": {"Name": "Frett B.", "AuthorID": "55215012300", "AffiliationID": "119027565", "AffiliationName": "Synactix Pharmaceuticals Inc."}, "57200988668": {"Name": "Zhang L.", "AuthorID": "57200988668", "AffiliationID": "60024885", "AffiliationName": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences"}, "57200992795": {"Name": "Lakkaniga N.R.", "AuthorID": "57200992795", "AffiliationID": "60024885", "AffiliationName": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences"}, "57207383526": {"Name": "Yan W.", "AuthorID": "57207383526", "AffiliationID": "60024885", "AffiliationName": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences"}, "37077499000": {"Name": "Li H.Y.", "AuthorID": "37077499000", "AffiliationID": "60024885", "AffiliationName": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences"}, "57216237559": {"Name": "Briggs D.C.", "AuthorID": "57216237559", "AffiliationID": "60107285", "AffiliationName": "Signalling and Structural Biology Laboratory, Francis Crick Institute"}, "57192558898": {"Name": "Chauhan R.", "AuthorID": "57192558898", "AffiliationID": "60107285", "AffiliationName": "Signalling and Structural Biology Laboratory, Francis Crick Institute"}, "7102832898": {"Name": "Mcdonald N.Q.", "AuthorID": "7102832898", "AffiliationID": "60009016", "AffiliationName": "Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College"}}}